Insulet (PODD)
(Delayed Data from NSDQ)
$181.42 USD
+4.23 (2.38%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $181.44 +0.03 (0.01%) 4:44 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Brokerage Reports
Insulet Corporation [PODD]
Reports for Purchase
Showing records 321 - 340 ( 341 total )
Company: Insulet Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
Q4 Revenues Grow 37% - Raising Target Price To $22 - BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
Q4 Revenues Grow 37% - Raising Target Price To $22 - BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
In-Line Q4-10; Banking on the next-gen OmniPod; Maintain Market Perform
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
In-Line Q4-10; Banking on the next-gen OmniPod; Maintain Market Perform
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
INCREASED FDA SCRUTINY LEADING TO LONGER APPROVAL TIMES
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Insulet Corporation
Industry: Medical - Products
MEETS Q3 EXPECTATIONS -MGT TIGHTENS GUIDANCE NO CHANGE ESTIMATE - BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
In-Line Q3-10; Regulatory headwinds could pose problems; Maintain Market Perform
Provider: RODMAN & RENSHAW, CO.
Company: Insulet Corporation
Industry: Medical - Products
THE NEXT PERFECT STORM-OBAMACARE WILL STRETCH THE SYSTEM TO ITS ULTIMATE LIMIT
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: Insulet Corporation
Industry: Medical - Products
In-Line Q2-10; In-Line Fiscal 2010 Guidance; Maintain Market Perform
Provider: RODMAN & RENSHAW, CO.
Analyst: KALIA S
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
70TH ANNUALAMERICAN DIABETES ASSOCIATION MEETING CONFIRMS THESIS - BUY
Provider: CAPSTONE INVESTMENTS
Analyst: PUTNAM J
Company: Insulet Corporation
Industry: Medical - Products
Company: Insulet Corporation
Industry: Medical - Products
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.